Shanghai Chest Hospital

This study is testing whether adding the drug dapagliflozin around the time of a heart ablation procedure can help prevent the irregular heartbeat from coming back. It will involve 280 adults with a specific type of long-lasting atrial fibrillation who have extra fat around the h…

This study is testing whether a medication for heart failure and high blood pressure (sacubitril/valsartan) can help people who have both advanced lung cancer and high blood pressure live longer. Researchers will follow 200 participants to see if the drug reduces deaths and serio…

This study is testing a new treatment approach for a rare chest cancer called locally advanced thymic carcinoma. It aims to see if giving a combination of immunotherapy, chemotherapy, and radiation *before* surgery can shrink tumors and make them easier to remove. The trial will …

This study is testing whether a combination of two drugs, SHR-A1811 and adebelimumab, can shrink tumors before surgery in people with early-stage, operable lung cancer that has a specific genetic marker called HER2. The goal is to see if this pre-surgery treatment helps eliminate…

This study is testing if adding a common type of diabetes pill (called an SGLT2 inhibitor) to standard cancer treatment can help people who have both advanced lung cancer and type 2 diabetes. Researchers want to see if these pills can help patients live longer or slow down the ca…

This study tests whether adding a kidney nerve treatment to a standard heart procedure helps prevent early irregular heartbeats in people with persistent atrial fibrillation. Researchers will compare the combined treatment against the standard procedure alone in 86 adults who are…

This study is testing a new mobile 4D CT scanner to see if it can create better 3D images of lung lesions during biopsy procedures. About 50 patients with lung lesions will have their scans taken with this new device. The goal is to help doctors see the lesion and biopsy tools mo…